相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bepridil is potent against SARS-CoV-2 in vitro
Erol C. Vatansever et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Disruption of disulfides within RBD of SARS-CoV-2 spike protein prevents fusion and represents a target for viral entry inhibition by registered drugs
Mateja Mancek-Keber et al.
FASEB JOURNAL (2021)
Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib
Jean-Claude Tardif et al.
AMERICAN HEART JOURNAL (2020)
Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus
Sen Liu et al.
BIOINFORMATICS (2020)
Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds
Andre Fischer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review
James M. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
SARS-CoV-2 productively infects human gut enterocytes
Mart M. Lamers et al.
SCIENCE (2020)
Rapid repurposing of drugs for COVID-19
R. Kiplin Guy et al.
SCIENCE (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
Structure of the RNA-dependent RNA polymerase from COVID-19 virus
Yan Gao et al.
SCIENCE (2020)
Potential anti-SARS-CoV-2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease
Motonori Tsuji
FEBS OPEN BIO (2020)
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
Chunlong Ma et al.
CELL RESEARCH (2020)
Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract
Jaewon J. Lee et al.
GENES (2020)
The molecular virology of coronaviruses
Ella Hartenian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor
Sanchita Hati et al.
ACS OMEGA (2020)
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
Wayne Vuong et al.
NATURE COMMUNICATIONS (2020)
Clinical Pharmacokinetics and Pharmacodynamics of Dalcetrapib
Donald M. Black et al.
CLINICAL PHARMACOKINETICS (2018)
Discovery of Covalent Ligands via Noncovalent Docking by Dissecting Covalent Docking Based on a Steric-Clashes Alleviating Receptor (SCAR) Strategy
Yuanbao Ai et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
Thanigaimalai Pillaiyar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib
Jean-Claude Tardif et al.
Circulation-Cardiovascular Genetics (2015)
Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib
Jean-Claude Tardif et al.
Circulation-Cardiovascular Genetics (2015)
Pharmacokinetics and disposition of dalcetrapib in rats and monkeys
Hiroaki Takubo et al.
XENOBIOTICA (2014)
Evidence for a role of CETP in HDL remodeling and cholesterol efflux: Role of cysteine 13 of CETP
Cyrille Maugeais et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Solubility and stability of dalcetrapib in vehicles and biological media
Guenter Gross et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Evidence of a Drug-Drug Interaction Linked to Inhibition of Ester Hydrolysis by Orlistat
Darren Bentley et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2012)
Determination of dalcetrapib by liquid chromatography-tandem mass spectrometry
Katja Heinig et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2012)
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Gregory G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy Subjects A Randomized, Double-Blind, Placebo-Controlled, Phase I Study
Michael Derks et al.
CLINICAL DRUG INVESTIGATION (2011)
Open Babel: An open chemical toolbox
Noel M. O'Boyle et al.
JOURNAL OF CHEMINFORMATICS (2011)
Mutation of Glu-166 Blocks the Substrate-Induced Dimerization of SARS Coronavirus Main Protease
Shu-Chun Cheng et al.
BIOPHYSICAL JOURNAL (2010)
Lack of effect of dalcetrapib on QT interval in healthy subjects following multiple dosing
Michael Derks et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
No clinically relevant drug-drug interactions when dalcetrapib is co-administered with atorvastatin
Michael Derks et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Biochemical characterization of cholesteryl ester transfer protein inhibitors
Mollie Ranalletta et al.
JOURNAL OF LIPID RESEARCH (2010)
Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport
Eric J. Niesor et al.
JOURNAL OF LIPID RESEARCH (2010)
A Single-Center, Open-Label, One-Sequence Study of Dalcetrapib Coadministered With Ketoconazole, and an In Vitro Study of the S-Methyl Metabolite of Dalcetrapib
Michael Derks et al.
CLINICAL THERAPEUTICS (2009)
Free Thiol Group of MD-2 as the Target for Inhibition of the Lipopolysaccharide-induced Cell Activation
Mateja Mancek-Keber et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Structural bioinformatics analysis of free cysteines in protein environments
Sheau Ling Ho et al.
JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS (2009)
Biophysical and biochemical approach to locating an inhibitor binding site on cholesteryl ester transfer protein
David Cunningham et al.
BIOCONJUGATE CHEMISTRY (2008)
Only one protomer is active in the dimer of SARS 3C-like proteinase
Hao Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
ZINC - A free database of commercially available compounds for virtual screening
JJ Irwin et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2005)
High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
JE Blanchard et al.
CHEMISTRY & BIOLOGY (2004)
The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor
HT Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)
A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits
H Okamoto et al.
NATURE (2000)
分享论文
